Validation and application of an immunoradiometric assay for the determination of human parathyroid hormone fragment 1-34 in dog plasma following subcutaneous and intravenous administration

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 12, 1996, Pages 1699-1707

  Seibel, Mary W ^a   Lade, Deborah A ^a   Hartke, James R ^a   Wehmeyer, Kenneth R ^a  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Immunoradiometric assay; Parathyroid hormone; Pharmacokinetics; Protease inhibitor cocktail; Stability

Indexed keywords

APROTININ; BENZAMIDINE; BENZYLSULFONYL FLUORIDE; EDETIC ACID; LEUPEPTIN; PARATHYROID HORMONE[1-34]; PEPSTATIN; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; DOG; DRUG DEGRADATION; DRUG DETERMINATION; DRUG STABILITY; IMMUNORADIOMETRIC ASSAY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030249743     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(96)01833-X     Document Type: Article

References (16)

1. [1] J.A. Prasons and B. Reit, Nature, 250 (1974) 254-257.
2. [2] J. Reeve, P.J. Meunier, J.A. Parsons, M. Bernat, O.L. Bijvoet, P. Courpron, C. Edouard, L. Klenerman, R.M. Neer, J.C. Renier, D. Slovik, F.J. Vismans and J.T. Potts, Jr., Br. Med. J., 280 (1980) 1340-1344.
3. [3] C.S. Tam, J.N. Heersche, T.M. Murray and J.A. Parsons, Endocrinology, 110 (1982) 506-512.
4. [4] R. Podbesek, C. Edouard, P.J. Meunier, J.A. Parsons, J. Reeve, R.W. Stevenson and J.M. Zanelli, Endocrinology, 112 (1983) 1000-1006.
5. [5] M. Gunness-Hey and J.M. Hock, Metab. Bone Dis. Relat. Res., 5 (1984) 177-181.
6. [6] D.M. Slovik, D.I. Rosenthal, S.H. Doppelt, J.T. Potts, Jr., M.A. Daly, J.A. Campbell and R.M. Neer, J. Bone Miner. Res., 1 (1986) 377-381.
7. [7] M. Rosenblatt, H.M. Kronenberg and J.T. Potts, Jr., in L.J. DeGroot (Ed.), Endocrinology, Vol. 2, W.B. Saunders, Philadelphia, PA, 1989, pp. 848-891.
8. [8] G.W. Tregear, J. Van Rietschoten, E. Green, H. Keutmann, H.D. Niall, J.A. Parsons and J.T. Potts, Jr., Endocrinology, 93 (1973) 1349-1353.
9. [9] R. Lindsay, J. Nieves, E. Henneman, V. Shen and F. Cosman, J. Clin. Endocrinol. Metab., 77 (1993) 1535-1539.
10. [10] E.K. Armitage, Clin. Chem., 32 (1986) 418-424.
11. [11] D.B. Endres, R. Villanueva, C.F. Sharp, Jr. and F.R. Singer, Endocrinol. Metab. Clin. N. Am., 18 (1989) 611-629.
12. [12] G.V. Segre and J.T. Potts, Jr., in L.J. DeGroot (Ed.), Endocrinology, Vol. 2, W.B. Saunders, Philadelphia, PA, 1989, pp. 984-1001.
13. [13] D.B. Endres and R.K. Rude, in C.A. Burtis and E.R. Ashwood (Eds.), Tietz Textbook of Clinical Chemistry, W.B. Saunders, Philadelphia, PA, 1994, p. 1920.
14. [14] M.R. Pandian, C.H. Morgan, E. Carlton and G.V. Segre, Clin Chem., 38 (1992) 282-288.
15. [15] W.D. Fraser, J. Robinson, R. Lawton, B. Durham, S.J. Gallacher, I.T. Boyle, G.H. Beastall and F.C. Logue, Clin. Chem., 39 (1993) 414-419.
16. [16] H. Daugaard, M. Egfjord, E. Lewin and K. Olgaard, Endocrinology, 134 (1994) 1373-1381.